The Cell Salt Co. Daily Blend 12 in 1 NDC 87674-100

NDC codes

FDA NDC Directory

Product NDC (as listed)87674-100Labeler and product segments. Claims need a package NDC.

Product NDC at billing width87674-0100Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
87674-100-10	87674010010	400 TABLET, SOLUBLE in 1 BOTTLE (87674-100-10)Marketed from Jul 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): The Cell Salt Co. Daily Blend 12 in 1
Generic name (nonproprietary): calc fluor, calc phos, calc sulph, ferrum phos, kali mur, kali phos, kali sulph, mag phos, nat mur, nat phos, nat sulph, silicea
Active ingredients: Ferrosoferric phosphate — 12 [hp_X]/1Sodium sulfate — 6 [hp_X]/1Calcium sulfate anhydrous — 6 [hp_X]/1Calcium fluoride — 12 [hp_X]/1Silicon dioxide — 12 [hp_X]/1Potassium chloride — 6 [hp_X]/1Sodium chloride — 6 [hp_X]/1Magnesium phosphate, Dibasic trihydrate — 6 [hp_X]/1Sodium phosphate, Dibasic, Heptahydrate — 6 [hp_X]/1Potassium phosphate — 6 [hp_X]/1Potassium sulfate — 6 [hp_X]/1Tribasic calcium phosphate — 6 [hp_X]/1
Dosage form: Tablet, Soluble
Route: Oral
Labeler: The Cell Salt Company LLC
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jul 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 87674-100_558261cb-4904-6f03-e063-6394a90a58e1SPL ID 558261cb-4904-6f03-e063-6394a90a58e1SPL set ID 55826f59-acf4-7370-e063-6394a90afed7UNII 91GQH8I5F7, 0YPR65R21J, E934B3V59H, O3B55K4YKI, ETJ7Z6XBU4, 660YQ98I10, 451W47IQ8X, HF539G9L3Q, 70WT22SF4B, B7862WZ632, 1K573LC5TV, 91D9GV0Z28
Pharmacologic class: Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N487674010010 followed by a unit qualifier and the quantity

Package 87674-0100-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 1, 2026.

Indications (excerpt from the label)

Uses Helps temporarily relieve: cold symptoms nervous tension fatigue headaches

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)